(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2-chloro-6-((3-iodobenzyl)amino)-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate

Catalog No. :
ACPWHX197
CAS No. :
1000980-70-0
Molecular Formula :
C23H23ClIN5O7
Molecular Weight :
643.82

IUPAC Name:(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(2-chloro-6-((3-iodobenzyl)amino)-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate

(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2-chloro-6-((3-iodobenzyl)amino)-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2-chloro-6-((3-iodobenzyl)amino)-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate
IUPAC Name(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(2-chloro-6-((3-iodobenzyl)amino)-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate
Molecular FormulaC23H23ClIN5O7
Molecular Weight643.82
SMILESIC1=CC(CNC2=C3N=CN([C@H]4[C@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O4)C3=NC(Cl)=N2)=CC=C1
InChI KeyOMCZTKULCXQZCI-WGQQHEPDSA-N
SynonymAdenosine, 2-chloro-N-[(3-iodophenyl)methyl]-, 2'',3'',5''-triacetate;2',3',5'-tri-O-acetyl-6-(3-iodobenzylamino)-2-chloropurineriboside
CAS No.1000980-70-0

Synthetic Route by SureRoute

1. ACPWHX197 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHJPY390 route compound structure diagram
    ACHJPY390696-41-3 In Stock
  4. Then
  5. ACPWHX197 route product structure diagram
    ACPWHX1971000980-70-0
Inquiry

2. ACPWHX197 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACETAD978 route compound structure diagram
    ACETAD97849617-83-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPWHX197 route product structure diagram
    ACPWHX1971000980-70-0
Inquiry

Comments (0)